 |
|
|
| |
Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Muir AJ,1 Jurkowski C,2 Cooney E,2 Hillson J,3 Lataillade M,2 Mas Casullo V,2 Gray T,3 Xu D,2 Yogendran L,2 Srinivasan S2
1Duke Clinical Research Institute, Duke University, Durham, NC; 2Bristol-Myers Squibb, Wallingford, CT; 3Bristol-Myers Squibb/Zymogenetics, Seattle, WA
|
| |
|
|
|
|
|
